Skip to content

Dynamic changes of inflammatory factors and platelet aggregation rate before and after percutaneous coronary intervention in patients with unstable angina pectoris and their effect on prognosis

Dynamic changes of inflammatory factors and platelet aggregation rate before and after percutaneous coronary intervention in patients with unstable angina pectoris and their effect on prognosis

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044938
Enrollment
Unknown
Registered
2021-03-31
Start date
2021-03-22
Completion date
Unknown
Last updated
2021-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Sponsors

The Second Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: For patients admitted to the Department of Cardiology of the Second Affiliated Hospital of Anhui Medical University who were diagnosed with coronary heart disease unstable angina pectoris and received PCI treatment, the diagnostic criteria for unstable angina pectoris were based on the standard diagnosis in the 2016 Guidelines for the Diagnosis and Treatment of Non-ST-segment Elevation Acute Coronary Syndrome in China.

Exclusion criteria

Exclusion criteria: 1.Patients who did not agree to participate in the study and were unable to follow the study protocol to complete the follow-up study; 2.Patients with severe infection, rheumatic connective tissue disease, malignancies, moderate or above anemia (hemoglobin less than 90g/L), and patients receiving glucocorticoid therapy were excluded; 3.Patients who had taken Ticagrelor in the week prior to admission were excluded; 4.There are any subjects that the investigator considers inappropriate to participate in the study.

Design outcomes

Primary

MeasureTime frame
major adverse cardiac events, MACE;

Secondary

MeasureTime frame
Clinically significant bleeding events;Treatment compliance;

Countries

China

Contacts

Public ContactSheng Jianlong

The Second Affiliated Hospital of Anhui Medical University

shengjianlong1982@163.com+86 15856940327

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026